Wednesday, 29 April 2026

European bank profits surge, UK distress climbs, and gold is squeezed between safe-haven buying and oil-led rate fears ahead of the Fed.

Signals

KNEBV.HE

Hold Kone — Deal terms and integration risk could pressure near-term valuation, limiting upside.

€56.30 -1.09%
OTIS

Watch Otis — A larger combined competitor may increase competitive pressure on Otis.

$77.36 -0.15%
UBS

Buy UBS — Multiple sources confirm profit surge, with trading gains from Middle East volatility fueling an 80% jump.

$42.10 -0.17%
DB

Buy Deutsche Bank — Stable earnings beat suggests operational momentum, though the signal is restated across WSJ sections.

$31.95 +0.09%
GSK.L

Buy GSK — Q1 beat driven by HIV, cancer, and immune disease medicines signals pipeline strength.

$2028 +0.60%
AZN

Buy AstraZeneca — Revenue and core earnings rose on strong oncology and rare-disease drug sales.

$13900 -0.52%
HLN.L

Sell Haleon — Underperformance from mild cold season hurts Q1 sales and may weigh on shares.

$350.8 +0.14%
GLD

Watch Gold — Central bank buying provides a floor, but oil-driven rate fears cap upside; wait for one force to dominate.

$421.9 -1.86%
USO

Watch Oil — Oil prices are a transmission channel from geopolitics to inflation and rate expectations.

$139.6 +3.62%
EWU

Hold UK equities — Rising corporate distress signals headwinds, but broad index may not fully reflect small-cap stress.

$46.55 -0.13%
AML.L

Sell Aston Martin — Another quarterly loss shows the turnaround is stalling, negative for the equity.

$39.94 -4.45%

Most original take

Giulia Petroni · WSJ Markets · 29 Apr 2026

Gold Squeezed Between Safe-Haven Allure, Rate Fears as Underlying Demand Holds

Gold is not just a safe haven but a vessel for two conflicting forces: central bank and investor buying on geopolitical fears, and rate-hike pressure from the oil price spike that the same geopolitics is driving. This squeeze means gold may disappoint bulls who expect a straightforward rally unless one force breaks decisively.

Read original ↗

Quote of the day

Preeti Soni, Jack Ryan · Bloomberg Markets · 29 Apr 2026

Central Banks ‘Scoop Up a Load’ of Gold in Bumpy First Quarter

Scoop up a load

Read original ↗

Our take

Today's signals point to a market that is picking winners and losers in a war-driven macro regime. European banks UBS and Deutsche Bank are thriving on volatility-linked trading gains, while UK equities show signs of distress as the Middle East war hits consumer demand and costs. Pharma diverges: GSK and AstraZeneca deliver on specialty drugs, but Haleon misses on a weak cold season. This is not a uniform cycle — it's a dispersion trade, and the press is flagging the cracks.

The easy bearish case on rates is dangerously crowded. TLT sits just 4% above its 52-week low, and the Fed could easily sound dovish enough to trigger a short squeeze in long duration. Meanwhile, oil (USO) is 3% off its 52-week high — if a ceasefire emerges, crude could tumble, unwinding the inflation scare that's pressuring gold and bonds. The very trades that feel obvious from the headlines are the ones with the most pain embedded on a reversal.

Notable absence: despite dollar strength and the Fed on deck, there is no coverage of Asian central bank reactions or EM vulnerability. If the Fed holds rates, the carry trade could snap hard, and EM currencies — silent in today's press — are the likely epicenter. Also, U.S. housing data and credit card delinquencies have disappeared from the radar; they would tell us if the real economy is buckling under these rates.

The cleanest expression of today's signals isn't a single ticker but a pairs trade: long UBS (beneficiary of volatility) against a basket of UK-exposed small caps, or simply holding gold as a tail hedge while recognizing it's not a one-way bet. Dispersion is rising; active management pays into these cross-currents.

Get tomorrow's digest Sent 7:30 UK time everyday